Feb 6, 2015 -
SWOG and The Hope Foundation are initiating a new Rare Cancers Fellowship. The Fellowship is a unique opportunity for a SWOG member to become involved in the planning and leadership of SWOG's Rare Cancers Program. By providing salary support to protect at least 25 percent of the Fellow's time, we aim to give a motivated SWOG member an opportunity to learn the mechanisms of the National Clinical Trials Network, and then to apply this knowledge to the development of rare cancer protocols that will be run in SWOG.
The Fellow will work closely with the Chair of SWOG's Early Therapeutics and Rare Cancer Committee (and other SWOG mentors) to help guide the development of rare cancer trials from concept through activation. We expect the Fellow to bring at least one rare cancer clinical trial to activation in SWOG within the two-year fellowship period.
Rare cancer research is a high-priority area of CTEP and the NCI, and the Fellow will work with these organizations and their programs, such as the International Rare Cancer Initiative and the NCI-MATCH trial, to enable clinical sites across the National Clinical Trials Network to open and accrue to SWOG rare cancer studies.
As with other programs such as our Coltman Fellowship and our Young Investigators Training Course, one of the goals of our Rare Cancer Fellowship is the development of future SWOG leaders.
Applicants should have a doctoral degree, proven experience in clinical trials development, and a faculty appointment at a SWOG member institution. Junior applicants should have a mentor currently active in SWOG.
The deadline for application for the Rare Cancers Fellowship is March 1, 2015. Application details are available online.